Back to search

Switzerland· 29223001

Tuscalman, sciroppo

A opium-derivate und expektoranzien product containing noscapinum, guaifenesinum, registered in Switzerland by Laboratorio Farmaceutico S.I.T. - Specialità igienico terapeutiche S.r.l., Mede, succursale di Chiasso and dispensed under Swissmedic category D. The same ATC class is registered in 5 of our 19 countries.

Cat D (Swissmedic)ATC R05FA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTuscalman, sciroppoATCR05FA02REGISTER NO.29223001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Opium-derivate und expektoranzien is registered in 5 of 19 countries.

Countries holding a registration under ATC R05FA02 (opium-derivate und expektoranzien), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 4 of them publish a price we can compare per daily dose

Opium-derivate und expektoranzien · ATC R05FA02

5 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
noscapinum, guaifenesinum
Manufacturer
Laboratorio Farmaceutico S.I.T. - Specialità igienico terapeutiche S.r.l., Mede, succursale di Chiasso
Country
Switzerland (CH)
ATC code
R05FA02
ATC class
Opium-Derivate und Expektoranzien
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Opium-derivate und expektoranzien in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All opium-derivate und expektoranzien products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Austria · Tuscalman
  • Belgium · Noscaflex Expectorans

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45cd414c-5bb5-485d-890b-0cc20d9bebf6
GET /v1/drugs/45cd414c-5bb5-485d-890b-0cc20d9bebf6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about opium-derivate und expektoranzien.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.